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Importance 
Mycoplasma gallisepticum is the most economically significant mycoplasmal 
pathogen of poultry. M. gallisepticum infections can cause significant economic 
losses on poultry farms from chronic respiratory disease, reduced feed efficiency, 
decreased growth and decreased egg production. The carcasses of birds sent to 
slaughter may also be downgraded. M. gallisepticum infections are notifiable to the 
World Organization for Animal Health (OIE). This organism has been eradicated 
from most commercial chicken and turkey breeding flocks in the United States; 
however, it remains endemic in many other poultry operations. 
Since 1994, M. gallisepticum conjunctivitis has become an emerging disease in 
finches. This disease has been responsible for major declines in house finch 
populations in the eastern U.S., and was recently reported in western house finch 
populations. M gallisepticum can also affect other finch species, although its impact 
has not been as severe. 
Etiology 
Avian mycoplasmosis can be caused by several species of Mycoplasma (class 
Mollicutes, order Mycoplasmatales, family Mycoplasmataceae) including Mycoplasma 
gallisepticum, M. synoviae, M. meleagridis and M. iowae. M. gallisepticum is the most 
important pathogen in poultry. It also causes disease in other avian species. M. 
gallisepticum infections are also known as chronic respiratory disease (CRD) of 
chickens, infectious sinusitis of turkeys and house finch conjunctivitis.  
Several strains of M. gallisepticum have been reported, including the R 
(poultry), P (psittacine) and house finch strains. Strains may vary greatly in their 
pathogenicity for different species of birds. In one study, budgerigars developed 
severe disease after experimental infection with the R strain of M. gallisepticum but 
not the house finch strain. 
Species Affected 
Mycoplasma gallisepticum causes disease in chickens, turkeys, and game birds 
including pheasants, chukar partridges, bobwhite quail, Japanese quail and peafowl. 
The organism has also been isolated from ducks and geese, as well as yellow-naped 
Amazon parrots, pigeons and greater flamingos. It has been found in wild peregrine 
falcons in Spain.  
Since 1994, M. gallisepticum epidemics have been reported in house finches 
(Carpodacus mexicanus) in the U.S. This organism has also been confirmed by 
culture or polymerase chain reaction (PCR) in American goldfinches (Carduelis 
tristis), purple finches (Carpodacus purpureus), eastern tufted titmice (Baeolophus 
bicolor), pine grosbeaks (Pinicola enucleator), evening grosbeaks (Coccothraustes 
vespertinus) and a captive blue jay (Cyanocitta cristata). PCR-positive mourning 
doves (order Columbiformes) have also been reported, but these birds remained 
seronegative and culture negative, and may have been infected by a related species of 
Mycoplasma. Other passerine species have tested positive by serology. House 
sparrows (Passer domesticus) and budgerigars (Melopsittacus undualtus) have been 
infected experimentally with some strains. 
Geographic Distribution 
M. gallisepticum can be found worldwide. In the United States, this organism has 
been eradicated from most commercial chicken and turkey breeding flocks, but 
remains present in other poultry operations. Beginning in 1994, M. gallisepticum 
epidemics associated with conjunctivitis were reported in house finches throughout 
the eastern U.S. Infected birds have recently been reported in house finch populations 
in the western U.S. 
Transmission 
M. gallisepticum is transmitted during close contact between birds as well as on 
fomites. Aerosol spread occurs over short distances and can be responsible for 
transmission within a flock. M. gallisepticum is also transmitted vertically in eggs.  
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Shedding in the egg can vary; egg transmission is more 
frequent in birds infected during laying than in birds 
infected before they mature. Infected birds carry M. 
gallisepticum for life, and can remain asymptomatic until 
they are stressed. 
Incubation Period 
Experimentally infected poultry develop symptoms 
after 6 to 21 days. In natural infections, the incubation 
period is variable; infected birds may be asymptomatic for 
days or months until stressed. In finches, incubation periods 
from 4 to 14 days have been reported.  
Clinical Signs 
M. gallisepticum infections vary from asymptomatic to 
severe, depending on the infecting strain and other factors. 
More severe infections are seen when the birds are infected 
concurrently with Newcastle disease virus, infectious 
bronchitis virus, Escherichia coli or other pathogens.  
Infected chickens usually develop respiratory 
symptoms that may include rales, coughing, sneezing, nasal 
discharges and dyspnea. Turkeys typically experience more 
severe disease, often accompanied by swelling of the 
paranasal (infraorbital) sinus. Conjunctivitis with a frothy 
ocular exudate is common in turkeys and occurs 
occasionally in chickens. Production is lower in infected 
flocks, with decreased weight gain, feed efficiency and egg 
production. The symptoms of avian mycoplasmosis are 
typically slow to develop, and the course of the disease can 
be prolonged. However, acute respiratory disease 
sometimes occurs in young birds, particularly turkeys. 
Avian mycoplasmosis has also been reported from 
other species of birds. In game birds, avian 
mycoplasmosis is characterized by upper respiratory 
disease, conjunctivitis lethargy, weight loss, decreased 
egg production and deaths. Conjunctivitis, sometimes 
accompanied by infraorbital sinus swelling, rhinitis, and 
ocular and nasal discharges, occurs frequently in house 
finches infected with M. gallisepticum. Conjunctivitis has 
also been reported in experimentally infected American 
goldfinches, pine siskins, purple finches and tufted 
titmice. In one study, the clinical signs were severe in 
house finches and American goldfinches, and milder in 
pine siskins and purple finches. In experimentally infected 
house finches and other passerine species, M. 
gallisepticum infections may take weeks or months to 
resolve; in one study, conjunctivitis persisted for an 
average of 7 weeks. Clinical disease has also been 
reported in psittacine birds including experimentally 
infected budgerigars. M. gallisepticum, together with M. 
iowae and an unidentified mycoplasma, was isolated from 
a flock of yellow-naped Amazon parrots with upper 
respiratory disease. The condition appeared to be caused 
by concomitant infections with mycoplasmas and bacteria, 
and the precise role of M. gallisepticum was not 
established. 
M. gallisepticum infections seem to be subclinical in 
some species of birds. House sparrows infected with the R 
(poultry) strain shed the organism transiently, but remained 
asymptomatic. In another study, budgerigars developed 
severe disease after experimental infection with the R strain 
of M. gallisepticum but not the house finch strain. 
Post Mortem Lesions      Click to view images 
In uncomplicated cases in chickens, the lesions 
typically include mild sinusitis, tracheitis and airsacculitis. 
If the chicken is infected concurrently with E. coli, 
thickening and turbidity of the air sacs, exudative 
accumulations, fibrinopurulent pericarditis and perihepatitis 
may be seen. In turkeys, severe mucopurulent sinusitis may 
be found, with variably severe tracheitis and airsacculitis. 
Lesions reported in naturally infected chukar partridges and 
pheasants include conjunctivitis and sinusitis of one or both 
infraorbital sinuses. Finches typically exhibit mild to severe 
inflammation in one or both eyes and the periorbital region. 
The eyelids may be swollen and inflamed, and a clear to 
cloudy, thickened ocular discharge may be noted. There 
may also be drainage from the nares.  
Morbidity and Mortality 
In the U.S., M. gallisepticum has been eradicated from 
most primary and multiplier poultry breeding flocks, but this 
organism can be endemic in large, multiple-age commercial 
egg laying flocks. Outbreaks also occur in meat flocks. 
Clinical cases tend to occur in large commercial operations 
during the winter. Stressors such as viral infections, 
vaccination with live viruses, cold weather or crowding can 
trigger disease outbreaks in infected flocks. In chickens with 
uncomplicated infections, the morbidity rate is high and the 
mortality rate low; however, more severe disease occurs if 
the birds are concurrently infected with other viruses or 
bacteria. Mortality rates can be high in turkeys. 
In wild songbirds, the impact of the disease is 
complicated by other factors. Under controlled 
experimental conditions, house finches exhibited morbidity 
rates approaching 100%, but low mortality rates of 
approximately 5% or less. However, the mortality rate can 
be high in wild house finches, probably due to 
environmental factors such as cold, predation and difficulty 
locating food and water. American goldfinches are also 
highly susceptible to experimental infection; however, in 
the wild, the morbidity rate is reported to be 2-3% in this 
species, compared to a 20-27% morbidity rate in free-living 
house finches. The cause of this discrepancy is unknown.  
Diagnosis  
Clinical 
M. gallisepticum infections should be considered in 
poultry or game birds with upper respiratory disease and 
wild house finches with conjunctivitis. Avian 
mycoplasmosis may also be a possibility in other species of 
passerine and psittacine birds, as well as blue jays. 
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Differential diagnosis 
In poultry, the differential diagnosis includes 
respiratory diseases such as infectious bronchitis, mild 
Newcastle disease and avian influenza. Hemophilus 
paragallinarum, Pasteurella multocida and Mycoplasma 
synoviae infections should also be ruled out. In turkeys, 
other pathogens to consider include avian pneumovirus, 
Pasteurella multocida, Chlamydia and M. synoviae. 
Mixed infections with M. gallisepticum and other 
organisms can occur. 
Laboratory tests 
M. gallisepticum infections can be diagnosed by 
culturing the organism on mycoplasma media. The 
colonies are tiny, circular, smooth and translucent, and 
sometimes have a “fried egg” appearance with a central 
dense mass. Biochemical tests can be useful in 
preliminary identification, but definitive identification is 
by indirect immunofluorescence, immunoperoxidase 
staining, a growth inhibition test, metabolism inhibition or 
PCR. Polymerase chain reaction/ restriction fragment 
length polymorphism (PCR-RFLP) may be necessary to 
distinguish M. gallisepticum from M. imitans. These two 
species can also be differentiated by immunofluorescence 
using serial dilutions of antisera to M. gallisepticum and 
M. imitans in parallel.  
M. gallisepticum can be difficult to grow directly from 
clinical samples, and PCR–based assays are commonly 
used for diagnosis. Animal inoculation, using mycoplasma–
free chicken embryos or chickens, is occasionally necessary 
to isolate the organism if these results of other tests are not 
conclusive; however, animal inoculation has largely been 
superceded by PCR. Immunological tests to detect antigens 
are generally not used directly on clinical samples, due to 
the very small size of the organisms and the absence of 
suitable negative and positive controls in many cases. 
Serology can also be used for diagnosis, and is 
particularly helpful in screening poultry flocks. Serology is 
less useful in individual birds, as nonspecific reactions are 
common. Commonly used assays include a rapid serum 
agglutination (RSA) test, enzyme–linked immunosorbent 
assays (ELISAs) and hemagglutination inhibition. Other 
tests including radioimmunoassay, microimmuno-
fluorescence and indirect immune-precipitation assays may 
be available.  
Samples to collect 
Swabs should be collected from affected organs, 
tissues and exudates for mycoplasma culture. In poultry, the 
samples can be taken from live birds, recently dead animals 
or carcasses frozen soon after death. There has been only 
limited success isolating M. gallisepticum from the frozen 
carcasses of house finches. In live poultry and other birds, 
swabs can be taken from the choanal cleft, oropharynx, 
esophagus, trachea, cloaca and phallus. At necropsy, samples 
can be collected from the air sacs, trachea, nasal cavity and 
infraorbital sinus. Aspirates can also be taken from the 
infraorbital sinuses or joint cavities. In addition, M. 
gallisepticum can be cultured from dead in-shell embryos, 
chickens or poults that have broken the shell but failed to 
hatch, and embryonated eggs. Tissues or swab samples can 
be transported in mycoplasma broth. Samples should be sent 
to the laboratory as soon as possible and kept chilled with an 
ice pack.  
Similar samples can also be used for PCR. One 
commercial test kit uses the material directly extracted from 
swabs. Serum samples should be collected from the flock 
for serology. 
Recommended actions if Mycoplasma 
gallisepticum infection is suspected 
Notification of authorities 
Mycoplasma gallisepticum infections are reportable in 
some states; state requirements should be consulted for 
more specific information.  
Federal: Area Veterinarians in Charge (AVIC): 
www.aphis.usda.gov/animal_health/area_offices/ 
State Veterinarians:   
www.usaha.org/Portals/6/StateAnimalHealthOfficials.pdf 
Control 
M. gallisepticum can be introduced into a flock by live 
birds or hatching eggs, as well as the movement of people 
and fomites. Subclinically infected small backyard flocks can 
be a source of infection for commercial poultry. In the U.S., 
lateral transmission is the most common means of 
introduction, as the disease has been eradicated from most 
primary and multiplier breeding flocks. M. gallisepticum–
negative breeding stock can be identified and maintained by 
serologic testing. Heat treatment or tylosin can eliminate egg 
transmission from valuable breeding animals. Biosecurity 
measures are important in preventing transmission on 
fomites. Wild or pet birds can also carry M. gallisepticum, 
and should be excluded from poultry operations.  
Infections can be eliminated from a farm by 
depopulation of the flock, followed by thorough cleaning 
and disinfection of the premises. Most commonly used 
disinfectants are thought to be effective for M. 
gallisepticum. Recommended disinfectants for buildings 
and equipment include phenolic or cresylic acid 
disinfectants, hypochlorite, and 0.1% glutaraldehyde. 
Mycoplasmas are typically fragile and only survive in the 
environment for a few days; birds can be re–introduced 
after 2 weeks. 
Eradication from large, multiple-age commercial egg 
laying flocks is complicated by persistent infections and 
periodic shedding under stress. In these flocks, M. 
gallisepticum infections may be treated with antibiotics, 
which decrease the clinical signs but do not eliminate the 
infection. Other concurrent infections must also be treated. 
Several live M. gallisepticum vaccines are available for 
chickens in the U.S.; permission from the state veterinarian 
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may be required for their use. An inactivated bacterin is also 
available in most countries. Vaccines are generally used to 
prevent egg-production losses and reduce the impact of 
respiratory disease in commercial layers, but they can also 
aid eradication, or reduce egg transmission in breeding 
stocks. Vaccination of turkeys with live vaccines is usually 
not recommended; however, newer live vaccines are less 
pathogenic for this species than the older (F strain) vaccine. 
One vaccine strain (6/85) has been tested in commercial 
turkeys in the U.S.  
Routine cleaning of bird feeders and disinfection with a 
10% solution of household bleach can reduce transmission 
in wild finches. Transmission at wild bird rehabilitation 
facilities should be minimized by good sanitation and 
disinfection; in one case, a blue jay contracted the infection 
from a house finch that had previously occupied the same 
cage. Consideration should be given to the possibility that 
M. gallisepticum may be present in poultry carcasses fed to 
raptors. 
Public Health 
Mycoplasma gallisepticum does not appear to be 
zoonotic. 
Internet Resources 
Manual for the Recognition of Exotic Diseases of Livestock 
http://www.spc.int/rahs/* 
The Merck Veterinary Manual 
http://www.merckvetmanual.com/mvm/index.jsp 
World Organization for Animal Health (OIE) 
http://www.oie.int 
OIE Manual of diagnostic Test and Vaccines for  
Terrestrial Animals 
http://www.oie.int/international-standard-
setting/terrestrial-manual/access-online/ 
OIE Terrestrial Animal Health Code 
http://www.oie.int/international-standard-
setting/terrestrial-code/access-online/ 
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